Usana Health Sciences (USNA) Net Margin (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Net Margin data on file, last reported at 2.78% in Q2 2026.

• Net Margin for Q2 2026 came in at 2.78%, down 94.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 0.99% (down 299.0% YoY), and the FY2026 annual result was 1.24%, down 368.0% from the prior year.
• Net Margin grew to 2.78% in Q2 2026 per USNA's latest filing, from 0.71% in the prior quarter.
• Over five years, Net Margin peaked at 8.23% in Q2 2022 and troughed at 3.12% in Q3 2025.
• A 5-year average of 4.85% and a median of 5.46% in 2023 frame the typical range for Net Margin.
• The sharpest annual moves came in 2023 and 2025: Net Margin surged 197 bps in 2023, then plunged 842 bps in 2025.
• A 5-year view of Net Margin shows it stood at 5.61% in 2022, then jumped by 35 bps to 7.58% in 2023, then plunged by 72 bps to 2.1% in 2024, then tumbled by 249 bps to 3.12% in 2025, then soared by 189 bps to 2.78% in 2026.
• Business Quant data shows USNA's Net Margin at 2.78% in Q2 2026, 0.71% in Q1 2026, and 3.12% in Q3 2025.